Certara Investor Day Presentation Deck

Differentiated strengths fuel global expansion 血 III Proprietary end-to-end software platform Biosimulation software adopted by 17 regulatory agencies Embedded in customers' R&D process with 90% renewal rate Scalable service model powered by technology and leading experts $M Revenue Nine Months by Region Ended Sept. 30 178.9 13.1 30.6 135.2 2020 44% 35% 11% Americas EMEA 10 210.8 18.9 41.2 150.6 2021 Asia Pac CERTARA

View entire presentation